Ennis (EBF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for July 17, 2025, with shareholders invited to vote on director elections, auditor ratification, and executive compensation approval.
Proxy materials are provided electronically to reduce costs and expedite delivery; shareholders can request paper copies.
Only shareholders of record as of May 16, 2025, are eligible to vote.
Voting matters and shareholder proposals
Shareholders will vote on electing two directors for three-year terms, ratifying CohnReznick LLP as independent auditor for fiscal 2026, and a non-binding advisory vote on executive compensation.
Board recommends voting FOR all proposals.
Cumulative voting rights are available for director elections.
Shareholder proposals for the 2026 meeting must be submitted by February 5, 2026.
Board of directors and corporate governance
Board consists of nine members in staggered three-year terms; majority are independent.
Two director nominees for 2025: Barbara T. Clemens (re-election) and Walter D. Gruenes (new nominee).
Board diversity includes gender and ethnic representation; 44% of directors are minorities or women.
Board committees: Audit, Compensation, and Nominating/Governance, all comprised of independent directors.
Annual board and committee self-evaluations are conducted.
Non-employee directors must maintain stock ownership equal to six times their annual retainer.
Latest events from Ennis
- EPS and gross margin rose on stable revenue, with acquisitions and cash strength supporting growth.EBF
Q3 20267 Jan 2026 - Annual meeting to vote on directors, auditor, and executive pay, with focus on governance and ESG.EBF
Proxy Filing2 Dec 2025 - Earnings rose 28% to $13.2M on flat sales, aided by a legal settlement and acquisitions.EBF
Q2 20263 Oct 2025 - Net sales fell 5.7%, but gross margin improved to 31.1% and cash flow remained strong.EBF
Q1 202630 Jun 2025 - Earnings and EPS rose despite lower revenue, with strong dividends and no debt.EBF
Q3 202513 Jun 2025 - Net sales dropped 7.3%, but EBITDA margin rose and a $2.50 special dividend was declared.EBF
Q2 202513 Jun 2025 - Revenue and earnings declined, but margins and cash position remain strong.EBF
Q1 202513 Jun 2025 - Revenue and earnings declined, but margins and cash position remain strong amid industry headwinds.EBF
Q4 20256 Jun 2025